
With a lawsuit, a House delay bill and drugmaker intervention motions in play, here's where HRSA's 340B rebate pilot stands ahead of Jan. 1.
Specialty Dispensing Insights delivers practice, clinic, and physician level perspective on oral therapy use within medically integrated dispensing (MID) pharmacies, including dose and days’ supply metrics, ZIP based activity, competitive prescribing, and trends in new patient starts. These insights offer clear visibility into how oral therapies are utilized within MID practices, helping teams understand the unique prescribing dynamics, geographic variation, and competitive activity across real-world community settings.






